Navigation Links
Mark G. Mishek Is New President and CEO of Hazelden
Date:8/25/2008

gagement in public policy, makes him an ideal leader for Hazelden."

"Hazelden is an outstanding organization with a rich legacy and a bright future," said Mishek. "I am honored and grateful to have been chosen by the board to lead such a highly respected, mission-driven company. Hazelden truly is an international leader in helping people sustain lifelong recovery to addiction to alcohol and other drugs. I'm excited to build upon Hazelden's strong foundation, started 60 years ago, to assure that its messages of hope and recovery reach the broadest possible audience."

Mishek earned a bachelor's degree and a law degree from the University of Minnesota. He is currently chair of the St. Paul Area Chamber of Commerce and serves on the boards of Capital City Partnership and ClearWay Minnesota. He has been a past board member of the Portico Healthnet. He lives with his family in St. Paul and is in long-term recovery from the disease of addiction.

"Mark's professional expertise and personal experiences in recovery are an integral match to Hazelden's mission," said William Cope Moyers, Executive Director of Hazelden's Center for Public Advocacy.

Mishek is expected to assume his new duties on November 3, 2008.

About the Hazelden Foundation

Hazelden, a national nonprofit organization founded in 1949, helps people reclaim their lives from the disease of addiction. With nearly 60 years of knowledge and experience, Hazelden offers a comprehensive approach to addiction that addresses the full range of patient, family, and professional needs, including treatment and continuing care for youth and adults, research, higher learning, public education and advocacy, and publishing. It has facilities in Minnesota, Oregon, Illinois, and New York.


'/>"/>
SOURCE Hazelden
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation
2. Dale Magner Joins Guardian as Vice President
3. WellPoint Announces Appointments of Lori Beer as Executive Vice President and Chief Information Officer; Martin Miller as Senior Vice President, Chief Accounting Officer and Controller
4. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
5. Prematics Names Dean M. Panovich Vice President, Deployment
6. Sonic Innovations Appoints New President and COO
7. Novis Pharmaceuticals Announces John W. Kilgour as Executive Vice-President of Sales & Marketing
8. Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer
9. Healthation Appoints New Vice President, Professional Services
10. WellPoint Appoints Krista A. Bowers as President of Senior Business
11. Pelosi Statement on Congress Sending Consumer Product Safety Legislation to President

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...FraternalOrderofPolicedistributedturkeys,cannedfoo..., PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNewswire/--...shipwiththeNewYorkStateFraternalOrderofPolice,host...k,sChildDevelopmentCenter,ProjectDiscoveryinPortJe...eivefreeturkeys,ham,chickenandothertrimmingstoprov...
(Date:11/24/2009)...-Mostpeoplelookforwardtokickingofftheholidayseason...ndfamily.TheMacombCountyHealthDepartmentremindsyou...lingandbeinginlargegroupsareeasywaystospreadfluger...VACCINATION ,, Thefirstandmostimportantstepisf...insttheH1N1strainoftheflu.TheMacombCountyHealthDep...
(Date:11/24/2009)...theholidayseasonoftenbringsfamiliesandfriendstoget...hosegrievingthedeathofalovedone.Followingadeath,ev...seasoncanbringadditionalchallengestothosewhoaregri...vingChildren,AdolescentsandTheirFamilies,isavailab...yofprintandonlineresourcesavailabletohelpchildreng...
(Date:11/24/2009)...ionLaborLifeInsuranceCompany("UnionLaborLife")anno...ion,slargestvisionbenefitsandservicescompany,topro...rustfunds,unionemployersandtheirmembers. ,, VSP...ngcomprehensiveeyeexams,broadselectionsofopticalfr...eis,"statedBruceSmith,NationalSales,VSP."Comprehen...
(Date:11/24/2009)...too loud, or contain dangerous chemicals , ...oliday shopping season begins, parents need to kno... stores across the United States. , That,s the ... report, released Tuesday by the U.S. Public Inter... on toys that pose a choking hazard, are excessive...
Breaking Medicine News(10 mins):Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 2Health News:Dangerous Toys Still on Store Shelves, Report Finds 3
...study, published in the June 6 issue of JAMA, has ...itary diffuse gastric cancer. It states that thes... events and common ancestry. The study has been re...ormation in the article, gastric cancer is the sec...
...SHINGTON, DC A new study published in the journal ...ssociation (APA), states that young adults with a ...promised lung function. The condition persisted ev...ur metropolitan areas (sampled from the Coronary A...
...ICAGO, A five-year follow-up of National Surgical...-31, presented at the annual meeting of the Americ... states that the risk of congestive heart failure ...rch team developed a prediction model based on the...
...ICAGO Findings presented today at the American So...alanis, M.D., a Mayo Clinic oncologist, reveals th...ws activity in patients with recurrent glioblastom... lead investigator of the study. Glioblast...
...itical care, emergency service and intensive care ... Rs.300 million boost from its new owner Fortis He....300 million) in Escorts within two years," Fortis...ot getting the desired focus for the last 20 month...
...cistm does upset those at the receiving end, even ...al slights and ambiguous remarks that are hard to ...overt discrimination, according to a study of 180 ...mptoms of depression and anxiety," said lead autho...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Unhealthy Lungs Linked to Hostility? 2Health News:Long-term Use of Herceptin Does Not Increase Heart Failure in Patients 2Health News:Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity 2Health News:Fortis to Inject Rs.300 Mn into Escorts Hospital 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2
(Date:11/24/2009)...ANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPharm...atthe21stAnnualPiperJaffrayHealthCareConferenceatT...p.m.EasternTime. ,, (Logo: http://www.newscom.c...audiowebcastofthispresentationwillbeaccessibleonth...pharma.com .Replaysofthispresentationwillbeavaila...
(Date:11/24/2009)...EWYORK,Nov.24/PRNewswire-FirstCall/--KeryxBiopharm...nBentsur,theCompany,sChiefExecutiveOfficer,issched...ConferencebeingheldinNewYorkCity. ,, Mr.Bentsur...r2ndat10:30AMETandwillbeaccessiblefromtheInvestorI...tors.keryx.com .Anarchivedversionofthewebcastwillb...
(Date:11/24/2009)...YNBROOK,N.Y.,Nov.24/PRNewswire-FirstCall/--BioSpec...uticalcompanydevelopingfirstinclasscollagenase-bas...t,TomWegman,willpresentattheupcomingPiperJaffray21...09,at3:30pmETatTheNewYorkPalaceHotelinNewYork,NY. ...der"CalendarofEvents"intheInvestorRelationssection...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 1Minorities have poorer results higher rates of inappropriate surgery to prevent stroke 55308 2Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 1Ellison Medical Foundation awards more than 241 million to mid career scientists 55303 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 1New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 2New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 3New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 4New Data Show ChloraPrep 28R 29 Significantly More Effective Than DuraPrep 28TM 29 and Povidone Iodine in Eliminating Bacteria From Skin Prior to Shou 55300 5
...sdaq: IOMI ) today announced that Stanley C. Erck...cer, will present at the Acumen BioFin,Rodman & Re... City on,Monday, Nov. 5. Mr. Erck,s presentation w... I Room of the New York Palace Hotel. Mr. Erck,s ...tch-based,needle-free vaccines and immunostimulant...
...alled POLI 1 -, BOSTON, Nov. 2 R1626, one of Roc...is C virus (HCV) infection, has,shown promising an...GASYS(R) (peginterferon alfa-2a) and COPEGUS(TM) (...t the American Association for the Study of the,Li... Nov. 2-6. After four,weeks of treatment with this...
Other Medicine Technology:Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7
Kremer Angled Fixation Forceps
...nsworth 100 Hue Test including MS-Excel scoring te... Farnsworth 100 Hue Test comes boxed in clear acry... the potential for test disruption by holding the... test from Richmond Products includes 93 color dis...
Farnsworth's D15 Test
... 4th edition pseudoisochromatic test from Richmond...the six screener plates and the 14 diagnostic seri...has its own tab for easy and clean page selection....nglish and a laminated copy of the score sheet. Th...
Medicine Products: